Financhill
Back

Genmab AS 10K Form

Sell
25

GMAB
Genmab AS

Last Price:
20.65
Seasonality Move:
5.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GMAB News And Ratings

See the #1 stock for the next 7 days that we like better than GMAB

GMAB Financial Statistics

Sales & Book Value

Annual Sales: $2.39B
Cash Flow: $301.53M
Price / Cash Flow: 14.03
Annual Sales: $7.53
Price / Book: 2.74

Profitability

EPS (TTM): 1.05240
Net Income (TTM): $684.26M
Gross Margin: $2.36B
Return on Equity: 14.86%
Return on Assets: 12.66%

Genmab AS Earnings Forecast

Key Genmab AS Financial Ratios

  • The Gross Profit Margin over the past 17 years for GMAB is 98.63%.
  • The Selling, General & Administrative Expenses for GMAB have been equal to 20.01% of Gross Profit Margin.
  • The Research & Development expenses have been 46.32% of Revenue.
  • The Interest Expense is 0.62% of Operating Income.
  • The Net Earning history of GMAB is 26.42% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 15 years.

Genmab AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GMAB
Website: genmab.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.17
Quick Ratio: 5.15

Price-to-Earnings

Trailing P/E Ratio: 21.54
Forward P/E Ratio: 13.06

GMAB Technical Analysis vs Fundamental Analysis

Sell
25
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy or a Sell?

  • Genmab AS stock is rated a Sell
    The current Genmab AS [GMAB] share price is $20.65. The Score for GMAB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.